MyProstateScore 2.0
- Aliases
-
- MPS2
- MyProstateScore 2.0
- Description
- From lynxdx.com: MyProstateScore 2.0 (MPS2) is a non invasive, genetically data-driven prostate cancer screening solution that provides highly accurate, stratified risk assessment insights to guide clinical decisions and improve your patients’ experience. The MPS2 algorithm has been developed to optimize accuracy. For biopsy naïve patients, MPS2 is a standalone biomarker test. For patients with a prior negative biopsy, relevant clinical factors are included in the algorithm. MPS2 is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 unique gene transcripts. Among the transcripts, the test’s foundation is the novel gene fusion, T2:ERG.
Attributes
- QA State
- Curated
- Type
- Genomic
- HGNC Name
- Certifications
- QA State for Prostate
- Curated
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.